NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$157.88M
Total Shares
975.1K
Net Share Change
+975.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$157.88M975.1K sharesNEW